Last 1,086 INR
Change Today -3.95 / -0.36%
Volume 7.1K
WYH On Other Exchanges
Natl India
As of 7:06 AM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

wyeth ltd (WYH) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/16/14 - 1,178
52 Week Low
10/18/13 - 560.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for WYETH LTD (WYH)

Related News

No related news articles were found.

wyeth ltd (WYH) Related Businessweek News

No Related Businessweek News Found

wyeth ltd (WYH) Details

Wyeth Limited engages in manufacturing, marketing, and trading pharmaceutical and consumer healthcare products primarily in India. It operates in Pharmaceuticals and Others segments. The company offers antibiotics, steroids, vaccines, vitamins and hematinics, pre-filled syringes and vials, and other prescription medicines, as well as women’s health care products, such as oral contraceptives, hormone replacement therapy, and other gynecologicals. It also provides products in the therapeutic areas of cardiovascular diseases, central nervous system, transplantation/immunology, gastrointestinal, ophthalmology, and antiparasitic; and OTC pharmaceuticals, cosmetics, and other allied consumer products. Wyeth Limited also exports its products to other countries. The company was formerly known as Wyeth Lederle Limited and changed its name to Wyeth Limited in April 2003. The company was incorporated in 1947 and is based in Mumbai, India. Wyeth Limited is a former subsidiary of Wyeth LLC.

Founded in 1947

wyeth ltd (WYH) Top Compensated Officers

Managing Director, Additional Non-Executive D...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

wyeth ltd (WYH) Key Developments

Wyeth Ltd Announces Resignation of D. E. Udwadia as Director

Wyeth Ltd. has announced that Mr. D. E. Udwadia has tendered his resignation as Director of the company with effect from August 26, 2014.

Wyeth Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

Wyeth Limited announced unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 1,911.8 million against INR 1,643.0 million a year ago. Profit from operations before other income, finance costs was INR 370.4 million against INR 247.7 million a year ago. Profit from ordinary activities before tax was INR 432.1 million against INR 338.7 million a year ago. Net profit from ordinary activities after tax was INR 284.6 million against INR 221.8 million a year ago. Basic and diluted earnings per share were INR 12.53 against INR 9.76 a year ago. EBITDA margins have improved to 20% compared to 15% reported a year ago.

Wyeth Limited to Report Q1, 2015 Results on Jul 25, 2014

Wyeth Limited announced that they will report Q1, 2015 results on Jul 25, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WYH:IN 1,085.75 INR -3.95

WYH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Array BioPharma Inc $3.48 USD -0.09
Dr. Datson's Labs Ltd 14.55 INR -0.75
GlaxoSmithKline SAE £14.00 EGP +0.07
Progenics Pharmaceuticals Inc $4.99 USD -0.20
Spectrum Pharmaceuticals Inc $8.09 USD -0.05
View Industry Companies

Industry Analysis


Industry Average

Valuation WYH Industry Range
Price/Earnings 26.0x
Price/Sales 3.5x
Price/Book 9.1x
Price/Cash Flow 25.2x
TEV/Sales 3.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WYETH LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at